Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0381 Transporter Info | ||||
Gene Name | SLC4A10 | ||||
Transporter Name | Sodium-driven chloride bicarbonate exchanger | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg05937737) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.85E+00 | Statistic Test | p-value: 3.14E-13; Z-score: 2.39E+00 | ||
Methylation in Case |
5.34E-01 (Median) | Methylation in Control | 2.88E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg04177287) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 5.78E-03; Z-score: -6.47E-01 | ||
Methylation in Case |
4.99E-01 (Median) | Methylation in Control | 5.45E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg24163360) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 4.22E-03; Z-score: -8.04E-01 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 7.97E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A10 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
3'UTR (cg17652998) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.47E-02; Z-score: -8.12E-01 | ||
Methylation in Case |
8.69E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg09715906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.38E+00 | Statistic Test | p-value: 3.15E-06; Z-score: -6.39E+00 | ||
Methylation in Case |
5.86E-01 (Median) | Methylation in Control | 8.08E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg20361238) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.08E-02; Z-score: -1.36E-01 | ||
Methylation in Case |
7.99E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A10 in bladder cancer | [ 2 ] | |||
Location |
Body (cg07262519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.83E+00 | Statistic Test | p-value: 9.58E-11; Z-score: -2.35E+01 | ||
Methylation in Case |
4.63E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A10 in bladder cancer | [ 2 ] | |||
Location |
3'UTR (cg06581825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.93E+00 | Statistic Test | p-value: 2.66E-08; Z-score: -9.34E+00 | ||
Methylation in Case |
4.61E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg20361238) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.51E-02; Z-score: -4.11E-01 | ||
Methylation in Case |
8.40E-01 (Median) | Methylation in Control | 8.82E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg09715906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 3.44E-02; Z-score: 1.98E-02 | ||
Methylation in Case |
7.62E-01 (Median) | Methylation in Control | 7.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A10 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg15240455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.89E-02; Z-score: 6.60E-01 | ||
Methylation in Case |
1.01E-01 (Median) | Methylation in Control | 8.42E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A10 in breast cancer | [ 3 ] | |||
Location |
Body (cg07262519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 9.94E-10; Z-score: -2.71E+00 | ||
Methylation in Case |
7.61E-01 (Median) | Methylation in Control | 8.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A10 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg06581825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.41E-06; Z-score: -8.50E-01 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.86E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in lung adenocarcinoma | [ 4 ] | |||
Location |
TSS1500 (cg09715906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 9.19E-03; Z-score: -1.72E+00 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.64E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in lung adenocarcinoma | [ 4 ] | |||
Location |
3'UTR (cg06581825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 2.22E-02; Z-score: -2.85E+00 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in panic disorder | [ 5 ] | |||
Location |
TSS1500 (cg09715906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.47E-02; Z-score: -2.64E-01 | ||
Methylation in Case |
2.12E+00 (Median) | Methylation in Control | 2.22E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in panic disorder | [ 5 ] | |||
Location |
TSS200 (cg15240455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 9.10E-01 | Statistic Test | p-value: 4.86E-02; Z-score: 5.04E-01 | ||
Methylation in Case |
-3.25E+00 (Median) | Methylation in Control | -3.57E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in papillary thyroid cancer | [ 6 ] | |||
Location |
TSS1500 (cg20361238) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.06E-02; Z-score: -8.77E-02 | ||
Methylation in Case |
8.92E-01 (Median) | Methylation in Control | 8.94E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in papillary thyroid cancer | [ 6 ] | |||
Location |
Body (cg07262519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.94E-04; Z-score: -5.79E-01 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 9.24E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A10 in papillary thyroid cancer | [ 6 ] | |||
Location |
3'UTR (cg06581825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.69E-02; Z-score: 7.84E-01 | ||
Methylation in Case |
9.50E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in systemic lupus erythematosus | [ 7 ] | |||
Location |
TSS1500 (cg20361238) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.96E-02; Z-score: -9.80E-02 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 8.93E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in systemic lupus erythematosus | [ 7 ] | |||
Location |
Body (cg07262519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.12E-02; Z-score: -4.93E-02 | ||
Methylation in Case |
8.50E-01 (Median) | Methylation in Control | 8.52E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in colorectal cancer | [ 8 ] | |||
Location |
TSS200 (cg15240455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.75E-02; Z-score: 3.52E-01 | ||
Methylation in Case |
1.63E-01 (Median) | Methylation in Control | 1.52E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg07262519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.28E-08; Z-score: -1.91E+00 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 9.15E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
TSS200 (cg15240455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 3.42E-02; Z-score: -1.03E+00 | ||
Methylation in Case |
9.62E-02 (Median) | Methylation in Control | 1.20E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg15573830) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.53E+00 | Statistic Test | p-value: 1.77E-15; Z-score: -3.34E+00 | ||
Methylation in Case |
3.28E-01 (Median) | Methylation in Control | 5.00E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
Body (cg15989525) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 1.43E-12; Z-score: -4.14E+00 | ||
Methylation in Case |
6.51E-01 (Median) | Methylation in Control | 8.10E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A10 in hepatocellular carcinoma | [ 9 ] | |||
Location |
3'UTR (cg06581825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.62E-07; Z-score: -1.95E+00 | ||
Methylation in Case |
8.73E-01 (Median) | Methylation in Control | 9.01E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in HIV infection | [ 10 ] | |||
Location |
TSS200 (cg15240455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 4.38E-02; Z-score: 3.62E-01 | ||
Methylation in Case |
1.63E-01 (Median) | Methylation in Control | 1.52E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in HIV infection | [ 10 ] | |||
Location |
Body (cg07262519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 8.15E-03; Z-score: -1.25E+00 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 8.65E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg02713266) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.23E-04; Z-score: -5.92E-01 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.84E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A10 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg07262519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.71E-03; Z-score: -3.40E-01 | ||
Methylation in Case |
7.48E-01 (Median) | Methylation in Control | 7.72E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A10 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
3'UTR (cg06581825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 1.44E-13; Z-score: -2.20E+00 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 9.04E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A10 in prostate cancer | [ 12 ] | |||
Location |
3'UTR (cg20536841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.96E-02; Z-score: 1.78E+00 | ||
Methylation in Case |
9.37E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Arterial aneurysm |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC4A10 in arterial aneurysm than that in healthy individual | ||||
Studied Phenotype |
Arterial aneurysm [ICD-11:BD51] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.00514222; Fold-change: 0.22774346; Z-score: 8.052608743 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Atypical teratoid rhabdoid tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC4A10 in atypical teratoid rhabdoid tumour than that in healthy individual | ||||
Studied Phenotype |
Atypical teratoid rhabdoid tumour [ICD-11:2A00.1Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.64E-08; Fold-change: 0.287142135; Z-score: 1.269651465 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC4A10 in melanocytoma than that in healthy individual | ||||
Studied Phenotype |
Melanocytoma [ICD-11:2F36.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 7.44E-07; Fold-change: 0.206614904; Z-score: 6.348297337 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC4A10 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 9.96E-19; Fold-change: 0.548319184; Z-score: 2.968912487 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC4A10 in melanoma than that in healthy individual | ||||
Studied Phenotype |
Melanoma [ICD-11:2C30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 9.90E-06; Fold-change: 0.561849083; Z-score: 2.841654786 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
microRNA |
|||||
Unclear Phenotype |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-30a directly targets SLC4A10 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | pSILAC//Proteomics;Other | ||
miRNA Stemloop ID |
miR-30a | miRNA Mature ID | miR-30a-5p | ||
miRNA Sequence |
UGUAAACAUCCUCGACUGGAAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.